| M05BB08 |
M05BB08 zoledronic acid, calcium and colecalciferol, sequential |
| M05BB09 |
M05BB09 ibandronic acid and colecalciferol |
| M05BC |
M05BC Bone morphogenetic proteins |
| M05BC01 |
M05BC01 dibotermin alfa |
| M05BC02 |
M05BC02 eptotermin alfa |
| M05BX |
M05BX Other drugs affecting bone structure and mineralization |
| M05BX01 |
M05BX01 ipriflavone |
| M05BX02 |
M05BX02 aluminium chlorohydrate |
| M05BX03 |
M05BX03 strontium ranelate |
| M05BX04 |
M05BX04 denosumab |
| M05BX05 |
M05BX05 burosumab |
| M05BX06 |
M05BX06 Romosozumab |
| M05BX07 |
M05BX07 Vosoritide |
| M05BX08 |
M05BX08 Menatrenone |
| M05BX53 |
M05BX53 Strontium ranelate and colecalciferol |
| M05BX53 |
M05BX53 strontium ranelate and colecalciferol |
| M09 |
M09 Other drugs for disorders of the musculo-skeletal system |
| M09A |
M09A Other drugs for disorders of the musculo-skeletal system |
| M09AA |
M09AA Quinine and derivatives |
| M09AA01 |
M09AA01 hydroquinine |
| M09AA72 |
M09AA72 quinine, combinations with psycholeptics |
| M09AB |
M09AB Enzymes |
| M09AB01 |
M09AB01 chymopapain |
| M09AB02 |
M09AB02 collagenase clostridium histolyticum |
| M09AB03 |
M09AB03 bromelains |
| M09AB52 |
M09AB52 trypsin, combinations |
| M09AX |
M09AX Other drugs for disorders of the musculo-skeletal system |
| M09AX01 |
M09AX01 hyaluronic acid |
| M09AX02 |
M09AX02 chondrocytes, autologous |
| M09AX03 |
M09AX03 Ataluren |